Biogen (BIIB) Receives New Analyst Coverage with Equal-Weight Rating

Feb 20, 2026

Key Takeaways

Barclays initiates coverage on Biogen (BIIB) with an Equal-Weight rating. New price target announced at $185.00 by analyst Emily Field.Tod

CONNECT & FOLLOW